Pursuant to clause 33 of the LODR, we enclose the following: a) Statement of unaudited Financial Results for the quarter ended 31.12.2018. b) The Limited Review Report on the said financials for the quarter ended 31.12.2018. The Board at its meeting held on 24.01.2019 considered and approved the unaudited financial results of the company for the quarter ended 31 12 2018. 1. Pursuant to clause 33 of the LODR, we enclose the following : a) Statement ofunaudited Financial Results for the quarter ended 31 12 2018. b) The Limited Review Report on the said financials for the quarter ended 31 12 2018. 2. The Board considered and approved the amalgamation of the Company with 1) Helios Solutions Ltd and 2) A-Diet Express Hospitality Service Ltd with the Company w.e.f. 01.04.2018 ( appointed date) subject to various approvals and sanctions to be obtained. Pursuant to SEBI''s circular : CFD/Dir3/CIR/2017 21/MAR, 10TH 2017 the Board will submit the draft documents for the said amalgamation as required under clause 37 of LODR and adopt the same in the next Board meeting. The scheme of said amalgamation will be hosted on the website of the Company upon submission of the documents with BSE. The Board meeting commenced at 3 pm and concluded at 6.15 pm. Please notify the above to the members of the stock exchange. In pursuant to regulation 30 of SEBI (LODR) Regulations, 2015 attaching herewith the observation letter received with respect to the Scheme of Arrangement. (As Per BSE Announcement dated on 21/11/2019) Outcome of Board meeting - Approval of draft Application to be filed with National Company Law Tribunal (NCLT) Chennai (As Per BSE Announcement Dated 03.12.2019) we wish to inform that the Hon'ble National Company Law Tribunal (NCLT), Chennai bench vide its order dated 5th August 2020 has approved the scheme of amalgamation for the merger of Helios Solutions Limited and A-Diet Express Hospitality Service Limited (Transferor Companies) with Indrayani Biotech Limited (Transferee Company). (As Per BSE Announcement Dated on 05.08.2020) 1. The Authorized capital of the Company has been increased from Rs 11,00,00,000 (Eleven crores) to Rs. 34,22,71,920 (Thirty-Four Crores twenty-two lakhs Seventy-One thousand Nine hundred and Twenty rupees) with effect from 15.09.2020 pursuant to merger order dated 05.08.2020 and corresponding fees has been paid to the Registrar of Companies, Chennai 2. Consequent to the issue and allotment of the equity shares under the Scheme of Amalgamation to the eligible members, the paid-up equity share capital of the Company stands increased from the present Rs. 3,64,38,600, divided into 36,43,860 equity shares of face value of Rs. 10/- each to Rs. 34,22,71, 920 divided into 3,42,27,192 equity shares of face value of Rs. 10/- each. (As Per BSE Announcement dated on 16.09.2020) We would like to inform that, the Hon'ble National Company Law Tribunal, Chennai Bench ('NCLT') on April 19, 2023 had approved the modifications in the Scheme of arrangement for proper implementation of the Scheme through an amendment to the 'Annexure to the Schedule'. We hereby request to take on record the copy of order passed by NCLT allowing the above amendment. (As per BSE Announcement Dated on 20/04/2023)